(*corresponding author)
- Cooper CG, Kafetzis KN, Patabendige A*, Tagalakis AD* (2024). Blood-brain barrier disruption in dementia: Nano-solutions as new treatment options. Eur J Neurosci. 59(6):1359-1385.
![Nanoparticles decorative image.](https://sites.edgehill.ac.uk/brainbarriers-research/files/2024/04/nanoparticles-1024x576.jpg)
- Patabendige A* (2022). An improved in vitro porcine blood-brain barrier model for permeability screening and functional studies. Methods Mol Biol. 2492:131-142.
![Brain cells image.](https://sites.edgehill.ac.uk/brainbarriers-research/files/2024/04/Brain-cells-page-4-1-1024x576.jpg)
- Aryal R and Patabendige A* (2021). Blood-brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes? Open Biol. 11(4):200396.
- Patabendige A*, Michael BD, Craig AG, Solomon T (2018). Brain microvascular endothelial-astrocyte cell responses following Japanese encephalitis virus infection in an in vitro human blood-brain barrier model. Mol Cell Neurosci. 89:60-70.
![Japanese virus](https://sites.edgehill.ac.uk/brainbarriers-research/files/2022/07/Japanese-encephalitis-virus-figure-Page-4-1024x584.jpg)
- Patabendige A*, Skinner RA, Abbott NJ* (2013). Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res. 1521:1-15.
![](https://sites.edgehill.ac.uk/brainbarriers-research/files/2022/07/Immuno-figure-Page-4-1024x756.jpg)